MRO
Protein maestro
Also known as: B29, C18orf3, FLJ30140, MSTRO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYG7
- Gene
- MRO
- Ensembl
- ENSG00000134042
- Chromosome
- 18
- Canonical length
- 248 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene is specifically transcribed in males before and after differentiation of testis, and the encoded protein may play an important role in a mammalian sex determination. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>Q9BYG7|MRO
1 MDQRQRRILG QPLSIPTSQP KQKRTSMISF FSKVSWKLRF QKREPLKNVF FILAERARDP
61 SAKKRHMAMR NLGTMAYEAP DKVRKYKKIV LDLLVYGLYD PVNLEVIHES MKTLTVVLGK
121 IQGKGLGSFF IDITLQTRTL LDDENDSLRY SAFVLFGQLA AFAGRKWKKF FTSQVKQTRD
181 SLLIHLQDRN PQVAKACKTT FQACSPYLKL KEEYSFQSEE DQRNTKLYQQ LSHYHPEILQ
241 FFYANKILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- midbrain: 36 nTPM
- basal ganglia: 36 nTPM
- amygdala: 33 nTPM
- cerebral cortex: 30 nTPM
- testis: 27 nTPM
- hypothalamus: 26 nTPM
Single-cell type
- sertoli cells: 104 nCPM
- astrocytes: 47 nCPM
- kupffer cells: 35 nCPM
- proximal tubule cells: 30 nCPM
- enterocytes: 21 nCPM
- adrenal medulla cells: 21 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- hypothalamus: 71 nTPM
- basal ganglia: 65 nTPM
- thalamus: 62 nTPM
- midbrain: 58 nTPM
- amygdala: 53 nTPM
- medulla oblongata: 51 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRO as an antibody target. Whether an autoantibody or antibody against MRO could matter depends on whether native MRO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRO is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MRO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...